Načítá se...
Improved outcomes on subcutaneous IgG in patients with humoral immunodeficiency and co-morbid bowel disease
Immunoglobulin replacement can be life-saving for certain individuals with immunodeficiencies. Subcutaneous IgG (SCIG) is an increasingly used method of replacement over intravenous IgG (IVIG), with potential advantages including fewer systemic side effects, no need for IV access, patient-reported i...
Uloženo v:
| Vydáno v: | Clin Case Rep Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813804/ https://ncbi.nlm.nih.gov/pubmed/27042340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15761/CCRR.1000149 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|